Business
/C O R R E C T I O N -- Apollo Medical Holdings, Inc./
In the news release, Apollo Medical Holdings, Inc. Reports Second Quarter 2023 Results, issued 07-Aug-2023 by Apollo Medical Holdings, Inc. over PR Newswire,
About this update from Astrana Health Inc.
[{"type":"text","content":"In the news release, Apollo Medical Holdings, Inc. Reports Second Quarter 2023 Results, issued 07-Aug-2023 by Apollo Medical Holdings, Inc. over PR Newswire, we are advised by the company that revisions have been made to the balance sheet and the accompanying footnote. The complete, corrected release follows:\n\nApollo Medical Holdings, Inc. Reports Second Quarter 2023 Results\n\n\nCompany to Host Conference Call on Monday, August 7, 2023, at 2:30 p.m. PT/5:30 p.m. ET\nALHAMBRA, Calif., Aug. 7, 2023 /PRNewswire/ -- Apollo Medical Holdings, Inc. (\"ApolloMed,\" and together with its subsidiaries and affiliated entities, the \"Company\") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced its consolidated financial results for the second quarter ended June 30, 2023.\n\n \n \n \n \n \n \n\n \nBrandon Sim, Co-Chief Executive Officer of ApolloMed, stated, \"Our strong second quarter performance reflects the sustained momentum and scalability of the ApolloMed model, with revenue up 29%, net income attributable to ApolloMed up 10%, and adjusted EBITDA up 44% compared to a year ago. We remain focused on our three key operational goals of growing our membership, empowering our providers, and improving patient outcomes, and we continue to drive meaningful progress in all three areas in California, Nevada, Texas, and beyond.\"\n\"We want to thank our providers and teammates for their hard work and dedication that resulted in our continued solid financial performance in the second quarter of 2023 and our confidence in reiterating our previously provided guidance for full-year 2023.\"\nFinancial Highlights for Second Quarter Ended June 30, 2023:\nAll comparisons are to the quarter ended June 30, 2022 unless otherwise stated.\nTotal revenue of $348.2 million, up 29% from $269.7 millionCare Partners revenue of $325.2 million, up 32% from $247.3 millionNet income attributable to ApolloMed of $13.2 million, up 10% from $12.0 millionAdjusted EBITDA of $35.8 million, up 44% from $24.9 millionFinancial Highlights for Six Months Ended June 30, 2023:\nAll comparisons are to the six months ended June 30, 2022 unless otherwise stated.\nTotal revenue of $685.5 million, up 29% from $533.0 millionCare Partners revenue of $639.9 mill...